2018
DOI: 10.1039/c8mt00089a
|View full text |Cite
|
Sign up to set email alerts
|

Vanadocene dichloride inhibits cell proliferation by targeting Aurora B

Abstract: Vanadocene dichloride (VDC) was shown to exhibit antitumor properties against a wide spectrum of tumor cell lines. Many studies have been carried out to reveal the bioactivities of VDC and the interaction mechanism of VDC with biological molecules in test tubes. One of the bioactivities of VDC is to arrest the cell cycle at the G2/M phase. However, its underlying mechanisms of action and cytotoxicity profile are still not fully understood. HeLa cells were used in this study, and the IC50 value of VDC was 8.61 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
4
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 23 publications
1
4
1
Order By: Relevance
“…We noted that typical chromosome alignment and spindle defects were observed as previously reported in Aurora B depletion or inhibition experiments. 70 Quantification of the H3S10ph signal versus the DAPI signal is represented in Figure 6B. The strongest reduction in the H3S10ph signal was obtained with compound CJ2-150 at 10 μM, similar to that obtained with ZM447439 at 1 μM.…”
Section: ■ Results and Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…We noted that typical chromosome alignment and spindle defects were observed as previously reported in Aurora B depletion or inhibition experiments. 70 Quantification of the H3S10ph signal versus the DAPI signal is represented in Figure 6B. The strongest reduction in the H3S10ph signal was obtained with compound CJ2-150 at 10 μM, similar to that obtained with ZM447439 at 1 μM.…”
Section: ■ Results and Discussionsupporting
confidence: 60%
“…Compared to the control, the H3S10ph signal was greatly reduced for both our compound and ZM447439 (Figure A). We noted that typical chromosome alignment and spindle defects were observed as previously reported in Aurora B depletion or inhibition experiments . Quantification of the H3S10ph signal versus the DAPI signal is represented in Figure B.…”
Section: Resultsmentioning
confidence: 99%
“…Interestingly, based on the IC 50 values in relation to vanadium concentration for the metallodrug candidates (S1-S4), it appears that a modest loading of vanadium, approximately 0.4%-1.0% into the cell lines, was sufficient to induce cytotoxicity (figure 8). In contrast, previous studies with vanadocene dichloride and cisplatin have required metal concentrations of up to 30%-65% [35][36][37]. Therefore, it can be inferred that the metallodrugfunctionalized nanostructured systems in this study enhance the delivery of the active vanadium species into the cell lines.…”
Section: Cytotoxicity Studiescontrasting
confidence: 61%
“…Vanadium compounds have been widely investigated due to a broad application in catalysis and a wide range of pharmacological properties. In the area of medicinal applications, the exploration of vanadium-based compounds has been focused on their insulin-mimetic properties, , anticancer activities, , antibacterial action, ,,, and effects on enzymes. ,,, In particular, bis­(ethylmaltolato)­oxidovanadium­(IV) (BEOV) entered the phase IIa clinical trials as an antidiabetic agent and its improved pharmacokinetics relative to vanadyl sulfate was evidenced. Vanadocene dichloride, (η 5 -C 5 H 5 ) 2 VCl 2 (C 5 H 5 = cyclopentadienyl), was demonstrated to have antitumor effects on a wide spectrum of cancer cells, including testicular cancer, leukemia, breast cancer, glioblastoma, and colon cancer. , Among oxidovanadium­(IV) derivatives, special attention has been devoted to bis­(4,7-dimethyl-1,10-phenanthroline)-sulfatooxidovanadium­(IV) (Metvan), which was found to induce apoptosis in leukemia, multiple myeloma, and solid tumors such as breast, prostate, testis, and glio...…”
Section: Introductionmentioning
confidence: 99%